Inventor · disambiguated record
Daniel P. Getman
Also filed as: GETMAN DANIEL · GETMAN DANIEL P
170 granted patents·20 pending applications·2,542 citations·filing 1984–2011
99Inventor score
Top patents by PatentIndex Score
190 records- 0198US6248775B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1999·Granted Jun 19, 2001·129 cites·18 claims
- 0298US6060476Aα- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1994·Granted May 9, 2000·77 cites·12 claims
- 0397US5965588ASulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1998·Granted Oct 12, 1999·66 cites·20 claims
- 0497US5744481Aβ-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1997·Granted Apr 28, 1998·51 cites·47 claims
- 0596US5968942Aα- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1994·Granted Oct 19, 1999·61 cites·23 claims
- 0696US5004558ASulfone peroxycarboxylic acidsMONSANTO CO·Filed 1988·Granted Apr 2, 1991·81 cites·48 claims
- 0795US6472407B1α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Oct 29, 2002·21 cites·20 claims
- 0895US6335460B1α-and β-amino acid hydroxyethlamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Jan 1, 2002·28 cites·26 claims
- 0995US5843946Aα-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1993·Granted Dec 1, 1998·78 cites·14 claims
- 1095US5482947ARetroviral protease inhibitorsFiled 1993·Granted Jan 9, 1996·38 cites·18 claims
- 1194US7320983B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Jan 22, 2008·8 cites·16 claims
- 1294US7141609B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2005·Granted Nov 28, 2006·13 cites·20 claims
- 1394US6500832B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Dec 31, 2002·21 cites·20 claims
- 1493US6846954B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2002·Granted Jan 25, 2005·16 cites·14 claims
- 1593US6417387B1α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2001·Granted Jul 9, 2002·24 cites·1 claims
- 1693US5508294ASulfonylalkanoylamino hydroxyethlamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Apr 16, 1996·41 cites·11 claims
- 1792US7115618B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2004·Granted Oct 3, 2006·12 cites·13 claims
- 1892US6534493B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted Mar 18, 2003·26 cites·29 claims
- 1992US6384036B1Bis-sulfonamide hydroxyethylamino retroviral protease inhibitorsSEARLE & CO·Filed 2000·Granted May 7, 2002·22 cites·16 claims
- 2091US7829564B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2007·Granted Nov 9, 2010·4 cites·16 claims
- 2191US7115632B1Sulfonyl aryl or heteroaryl hydroxamic acid compoundsSEARLE & CO·Filed 2000·Granted Oct 3, 2006·33 cites·55 claims
- 2291US6924286B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2003·Granted Aug 2, 2005·16 cites·20 claims
- 2391US6875790B2Cyclic sulfone containing retroviral protease inhibitorsSEARLE & CO·Filed 2003·Granted Apr 5, 2005·16 cites·20 claims
- 2490US7339078B2Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Mar 4, 2008·6 cites·18 claims
- 2590US7161033B2Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2005·Granted Jan 9, 2007·6 cites·20 claims
- 2690US6646010B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 2002·Granted Nov 11, 2003·16 cites·12 claims
- 2790US6552203B2Cyclic sulfone containing retroviral protease inhibitorsMONSANTO CO·Filed 2001·Granted Apr 22, 2003·16 cites·3 claims
- 2890US6022872Aα- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitorsSEARLE & CO·Filed 1996·Granted Feb 8, 2000·27 cites·42 claims
- 2990US5610190ARetroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Mar 11, 1997·27 cites·48 claims
- 3090US5578606Aα- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitorsSEARLE & CO·Filed 1992·Granted Nov 26, 1996·27 cites·6 claims
- 3190US5510388ASulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Apr 23, 1996·27 cites·16 claims
- 3289US6172082B1α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Jan 9, 2001·24 cites·49 claims
- 3388US7531538B2α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted May 12, 2009·6 cites·19 claims
- 3488US6750228B1Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2000·Granted Jun 15, 2004·35 cites·44 claims
- 3587US6455581B1α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Sep 24, 2002·20 cites·26 claims
- 3687US6022994ASuccinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1998·Granted Feb 8, 2000·23 cites·40 claims
- 3787US5025021A1,2-dideoxy-2-fluoronojirimycin as glycosidase inhibitorsMONSANTO CO·Filed 1989·Granted Jun 18, 1991·22 cites·19 claims
- 3886USRE43596Eα- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsVAZQUEZ MICHAEL L·Filed 2007·Granted Aug 21, 2012·3 cites·15 claims
- 3986US6683093B2Aromatic sulfone hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2001·Granted Jan 27, 2004·27 cites·93 claims
- 4086US5521219ASulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1993·Granted May 28, 1996·54 cites·13 claims
- 4186US4879398AProcess for producing 2,6-disubstituted tyrosineMONSANTO CO·Filed 1987·Granted Nov 7, 1989·23 cites·12 claims
- 4285US6313345B1Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1999·Granted Nov 6, 2001·19 cites·172 claims
- 4385US5786483Aα-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Jul 28, 1998·26 cites·28 claims
- 4485US5026713A1,3-dideoxy-3-fluoronojirimycin which inhibits glycosidase activityMONSANTO CO·Filed 1989·Granted Jun 25, 1991·19 cites·27 claims
- 4585US4758369ASulfone peroxycarboxylic acidsMONSANTO CO·Filed 1987·Granted Jul 19, 1988·17 cites·14 claims
- 4684US6143747ABis-sulfonamide hydroxyethylamino retroviral protease inhibitorsSEARLE & CO·Filed 1996·Granted Nov 7, 2000·21 cites·16 claims
- 4784US5703076ARetroviral protease inhibitorsSEARLE & CO·Filed 1995·Granted Dec 30, 1997·23 cites·35 claims
- 4882USRE43802Eα- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsVAZQUEZ MICHAEL L·Filed 2011·Granted Nov 13, 2012·1 cites·41 claims
- 4982US6861539B1Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE & CO·Filed 2003·Granted Mar 1, 2005·10 cites·20 claims
- 5082US6506759B1Retroviral protease inhibitorsMONSANTO CO·Filed 2000·Granted Jan 14, 2003·6 cites·40 claims
Showing the top 50 of 190 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel P. Getman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →